• Clozapine N-oxide: Chemogenetic Actuator for Precise Neur...

  2026-01-04

  Clozapine N-oxide (CNO) is redefining neuroscience by enabling reversible, non-invasive control of neuronal circuits through DREADDs technology. As a biologically inert metabolite of clozapine, CNO stands out for its specificity, scalability, and reliability in GPCR signaling and psychiatric disorder modeling.

• Cisapride (R 51619): Precision in Cardiac Electrophysiolo...

  2026-01-03

  Cisapride (R 51619) empowers researchers to dissect 5-HT4 receptor signaling and hERG channel inhibition with unparalleled precision in cardiac electrophysiology and drug safety studies. Its compatibility with iPSC-derived models and high-content screening workflows accelerates predictive cardiotoxicity assessments and de-risks early-stage drug discovery. Trust APExBIO to deliver high-purity Cisapride for robust, reproducible results in advanced translational research.

• Cisapride (R 51619): Driving Innovation in Cardiac Electr...

  2026-01-02

  Cisapride (R 51619) stands out as both a nonselective 5-HT4 receptor agonist and a potent hERG potassium channel inhibitor, making it indispensable for advanced cardiac electrophysiology and phenotypic screening workflows. By enabling high-throughput, predictive modeling of arrhythmogenic risk and 5-HT4 signaling, Cisapride from APExBIO accelerates translational research and de-risks cardiac drug discovery.

• Clozapine N-oxide (CNO): Reliable Chemogenetic Actuator f...

  2026-01-01

  This article equips biomedical researchers with scenario-driven best practices for optimizing cell viability and neuronal modulation assays using Clozapine N-oxide (CNO, SKU A3317). Drawing from validated literature and real-world lab challenges, the piece highlights CNO’s specificity, solubility, and reproducibility advantages, guiding scientists to robust results and streamlined workflows.

• Lamotrigine in Translational Neuroscience: Mechanistic In...

  2025-12-31

  This thought-leadership article explores the multifaceted role of Lamotrigine—an advanced sodium channel blocker and 5-HT inhibitor—in shaping translational neuroscience and cardiovascular research. By integrating mechanistic detail, high-throughput experimental strategies, and the latest blood-brain barrier (BBB) modeling innovations, we provide actionable guidance for researchers aiming to optimize CNS drug workflows and accelerate bench-to-bedside breakthroughs.

• Lamotrigine as a Translational Research Catalyst: Mechani...

  2025-12-30

  This thought-leadership article examines Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) as a high-purity sodium channel blocker and 5-HT inhibitor, blending mechanistic detail with experimental guidance for translational CNS and cardiac researchers. It contextualizes Lamotrigine’s role within emerging high-throughput blood-brain barrier (BBB) models, offers actionable workflow optimization, and charts a strategic path forward for clinical translation, all while highlighting APExBIO’s rigorous product standards.

• Cisapride (R 51619): Precision Phenotyping and Next-Gen C...

  2025-12-29

  Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist and hERG potassium channel inhibitor, is revolutionizing cardiac electrophysiology research. This article uniquely focuses on integrating deep learning and iPSC-derived cardiomyocytes for advanced cardiac safety and phenotypic screening applications.

• Amitriptyline HCl in Neuropharmacology: Optimizing BBB Mo...

  2025-12-28

  Amitriptyline HCl stands out as a versatile serotonin/norepinephrine receptor inhibitor, powering next-generation blood-brain barrier (BBB) modeling and neurotransmitter pathway studies. This guide delivers hands-on workflows, advanced troubleshooting, and expert insights for maximizing experimental impact in neurodegenerative and mood disorder research.

• Amitriptyline HCl: Mechanistic Benchmarks for Neuropharma...

  2025-12-27

  Amitriptyline HCl is a tricyclic serotonin/norepinephrine receptor inhibitor with validated utility in neurotransmitter receptor modulation and blood-brain barrier (BBB) model benchmarking. Its precise pharmacological profile and robust solubility make it a preferred tool for translational neuropharmacology and CNS drug discovery. This article details the compound’s mechanism, experimental parameters, and integration into high-throughput workflows.

• Perospirone (SM-9018 Free Base): Mechanism, Benchmarks, a...

  2025-12-26

  Perospirone (SM-9018 free base) is a potent atypical antipsychotic agent for schizophrenia research, acting as a 5-HT2A and D2 receptor antagonist and 5-HT1A partial agonist. Recent findings show it also inhibits vascular Kv1.5 channels, expanding its relevance for modeling neuropsychiatric and cardiovascular comorbidities. This dossier details receptor affinities, validated off-target effects, and practical research applications.

• Cimetidine as a Translational Research Catalyst: Mechanis...

  2025-12-25

  Explore how Cimetidine's unique partial agonist activity at the H2 receptor, distinct from traditional antagonists, is reshaping translational research in gastrointestinal cancers and beyond. This thought-leadership article navigates mechanistic advancements, experimental best practices, competitive benchmarking, and emerging clinical relevance. Drawing on data from high-throughput BBB models and robust cell-based assay protocols, it provides actionable guidance for researchers seeking reproducible results and new therapeutic insights.

• Perospirone: Atypical Antipsychotic for Schizophrenia Res...

  2025-12-24

  Perospirone (SM-9018 free base) is redefining schizophrenia research by uniquely bridging serotonergic, dopaminergic, and ion channel biology. Its robust receptor profile and off-target Kv1.5 inhibition empower scientists to model neuropsychiatric and cardiovascular comorbidities with unprecedented precision.

• Lamotrigine in CNS Research: Beyond Blockade to Blood-Bra...

  2025-12-23

  Explore the multifaceted role of Lamotrigine, a sodium channel blocker and 5-HT inhibitor, in advanced blood-brain barrier and epilepsy research. This article uniquely connects in vitro permeability models with translational CNS applications, offering new perspectives for experimental design.

• Cimetidine (SKU B1557): Data-Driven Solutions for Cell-Ba...

  2025-12-22

  This article examines how Cimetidine (SKU B1557) from APExBIO enables robust, reproducible results in cell viability, proliferation, and cytotoxicity studies. Through scenario-driven Q&A, we highlight its distinct pharmacological profile, solubility, and reliability, providing actionable insights for biomedical researchers and lab technicians seeking data-backed solutions.

• Amitriptyline HCl: Precision Serotonin/Norepinephrine Inh...

  2025-12-21

  Amitriptyline HCl, a tricyclic serotonin/norepinephrine receptor inhibitor, offers robust, verifiable pharmacodynamic properties for neuropharmacology research. This article details its mechanism, benchmarks its application in advanced blood-brain barrier (BBB) models, and clarifies optimal experimental integration, establishing APExBIO’s B2231 product as a high-utility reagent for CNS drug development.

15488 records 2/1033 page Previous Next 12345 下5页 Last page